KR100685553B1 - 폴리실록산 및 양친매성 용매를 기초로 한 미소저장기 시스템 - Google Patents
폴리실록산 및 양친매성 용매를 기초로 한 미소저장기 시스템 Download PDFInfo
- Publication number
- KR100685553B1 KR100685553B1 KR1020017016758A KR20017016758A KR100685553B1 KR 100685553 B1 KR100685553 B1 KR 100685553B1 KR 1020017016758 A KR1020017016758 A KR 1020017016758A KR 20017016758 A KR20017016758 A KR 20017016758A KR 100685553 B1 KR100685553 B1 KR 100685553B1
- Authority
- KR
- South Korea
- Prior art keywords
- solvent
- transdermal therapeutic
- polysiloxane
- therapeutic system
- weight
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (17)
- 활성 물질 불투과성 배면층, 내재된 미소저장기 및 그 중에 용해된 1종 이상의 활성 물질을 갖는 1개 이상의 중합체층, 및 사용전 제거되는 보호층을 포함하며;하기 특성의 조합을 특징으로 하는 경피 치료 시스템:a) 중합체층의 중합체 부분이 70중량% 이상의 가용성 폴리실록산으로 이루어짐,b) 활성 물질의 용매가 50중량% 이상의 양친매성 용매로 이루어짐, 및c) 양친매성 용매가 폴리실록산 중에 20중량% 이하로 용해되며 물과 1:3(용매:물) 이상의 중량비로 혼화됨.
- 제 1 항에 있어서,폴리실록산이 아민 내성인 경피 치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,제조후 미소저장기에 물이 존재하지 않는 경피 치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,폴리실록산이 자가 접착성이고 1종 이상의 충전제를 포함하는 경피 치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,미소저장기 포함 층이 피부에 고정 및/또는 배면층에 고정시키기 위한, 미소저장기가 존재하지 않는 1개 이상의 자가 접착성 층을 추가로 구비하는 경피 치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,양친매성 용매가 실온에서 액상이고; 표준조건하 80℃ 초과의 비점을 가지며; 디에틸렌 글리콜 모노에틸 에테르, 디에틸렌 글리콜 디메틸 에테르, 부탄디올, 테트라히드로푸르푸릴 알코올, 디프로필렌 글리콜, 프로필렌 글리콜 또는 이들의 혼합물이고; n-헥산 또는 n-헵탄 중에 20중량% 이하로 용해되는 경피 치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,양친매성 용매의 비점이 폴리실록산의 용매의 비점 초과인 경피 치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,미소저장기의 최대 크기가 중합체층의 두께의 80% 이하이며, 미소저장기가 평균 5 내지 50㎛의 직경을 갖는 경피 치료 시스템.
- 제 1 항 또는 제 2 항에 있어서,미소저장기가 활성 물질 및 양친매성 용매에 추가적으로, 결정화 방지제, 점도증강제 및/또는 pH 조절제를 포함하는 경피 치료 시스템.
- 활성 물질을 50중량% 이상의 양친매성 유기 용매로 이루어진 양친매성 용매 중에 용해시키는 단계, 생성된 용액을 폴리실록산의 용액 중에 분산시키는 단계, 생성된 분산액을 적절한 필름 상에 피복하는 단계, 및 25 내지 100℃의 온도에서 폴리실록산의 용매를 제거하는 단계를 포함하는, 경피 치료 시스템에 적합하며 활성 물질의 미소저장기로 충전된 폴리실록산 중합체층의 제조 방법.
- 제 1 항에 있어서,중합체층의 중합체 부분이 80중량% 이상의 가용성 폴리실록산으로 이루어지고, 활성 물질의 용매가 80중량% 이상의 양친매성 용매로 이루어진 경피 치료 시스템.
- 제 1 항 또는 제 11 항에 있어서,양친매성 용매가 양극성 유기 용매인 경피 치료 시스템.
- 제 6 항에 있어서,양친매성 용매가 110℃ 초과의 비점을 갖는 경피 치료 시스템.
- 제 7 항에 있어서,양친매성 용매의 비점이 10℃ 이상인 경피 치료 시스템.
- 제 14 항에 있어서,양친매성 용매의 비점이 30℃ 이상인 경피 치료 시스템.
- 제 8 항에 있어서,미소저장기가 5 내지 25㎛의 직경을 갖는 경피 치료 시스템.
- 제 10 항에 있어서,30 내지 80℃의 온도에서 폴리실록산의 용매를 제거하는 제조 방법.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19930340.1 | 1999-07-02 | ||
DE19930340 | 1999-07-02 | ||
DE19958554.7 | 1999-12-04 | ||
DE19958554A DE19958554C2 (de) | 1999-07-02 | 1999-12-04 | Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020015359A KR20020015359A (ko) | 2002-02-27 |
KR100685553B1 true KR100685553B1 (ko) | 2007-02-22 |
Family
ID=7913294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017016758A KR100685553B1 (ko) | 1999-07-02 | 2000-06-20 | 폴리실록산 및 양친매성 용매를 기초로 한 미소저장기 시스템 |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR100685553B1 (ko) |
AR (1) | AR033946A1 (ko) |
DE (3) | DE19958554C2 (ko) |
IL (1) | IL147247A (ko) |
ZA (1) | ZA200110455B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10141651B4 (de) * | 2001-08-24 | 2007-02-15 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung |
DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
PL219512B1 (pl) * | 2003-04-14 | 2015-05-29 | Lohmann Therapie Syst Lts | Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego |
KR101148315B1 (ko) * | 2003-08-07 | 2012-07-05 | 에르테에스 로만 테라피-시스테메 아게 | 피복 박편상에 방벽 효과를 지닌 오르모서를 포함하는 피부 또는 경피성 치료학적 제제 |
DE10348046A1 (de) * | 2003-10-16 | 2005-05-19 | Beiersdorf Ag | Verfahren zur Herstellung von Matrizes für transdermale oder topicale Wirkstoffsysteme |
CA2544291C (en) * | 2003-10-27 | 2013-01-08 | University Of Basel | Transdermal drug delivery method and system |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
DE102007041557B4 (de) * | 2007-08-29 | 2011-03-31 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System enthaltend längliche Hohlkörper |
EP2729148A4 (en) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE |
TW201338813A (zh) | 2011-12-12 | 2013-10-01 | Lohmann Therapie Syst Lts | 經皮遞送系統 |
US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
JP6559121B2 (ja) | 2013-06-04 | 2019-08-14 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮送達システム |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
DE102018118507A1 (de) * | 2018-07-31 | 2020-02-06 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2153533C3 (de) * | 1971-10-27 | 1974-12-12 | Varta Batterie Ag, 3000 Hannover | Elektrische Akkumulatorenzelle |
DE3333240A1 (de) * | 1983-09-12 | 1985-03-28 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mittel zur transdermalen applikation von arzneimittelwirkstoffen |
US4883669A (en) * | 1985-02-25 | 1989-11-28 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration |
DE3685895T2 (de) * | 1985-02-25 | 1992-12-24 | Univ Rutgers | Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen. |
-
1999
- 1999-12-04 DE DE19958554A patent/DE19958554C2/de not_active Expired - Lifetime
-
2000
- 2000-06-20 DE DE50001450T patent/DE50001450D1/de not_active Expired - Lifetime
- 2000-06-20 DE DE2000501450 patent/DE122006000008I1/de active Pending
- 2000-06-20 KR KR1020017016758A patent/KR100685553B1/ko active IP Right Grant
- 2000-06-30 AR ARP000103345A patent/AR033946A1/es active IP Right Grant
-
2001
- 2001-12-20 ZA ZA200110455A patent/ZA200110455B/xx unknown
- 2001-12-23 IL IL147247A patent/IL147247A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL147247A (en) | 2006-12-31 |
AR033946A1 (es) | 2004-01-21 |
KR20020015359A (ko) | 2002-02-27 |
DE19958554C2 (de) | 2002-06-13 |
DE122006000008I1 (de) | 2006-06-29 |
ZA200110455B (en) | 2002-10-16 |
DE50001450D1 (de) | 2003-04-17 |
DE19958554A1 (de) | 2001-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10709669B2 (en) | Microreservoir system based on polysiloxanes and ambiphilic solvents | |
KR100685553B1 (ko) | 폴리실록산 및 양친매성 용매를 기초로 한 미소저장기 시스템 | |
KR100895188B1 (ko) | 활성성분으로서 펜타닐을 함유하는 경피치료 시스템 | |
JP5695562B2 (ja) | 安定化された経皮薬物送達システム | |
US7413747B2 (en) | Transdermal therapeutic system for treating Parkinsonism | |
JP2004514738A (ja) | 活性物質としてオキシブチニンで構成される経皮治療システム | |
EP2259780A2 (en) | Pharmaceutical composition comprising naltrexone | |
KR100624500B1 (ko) | 레리세트론 전달용 경피치료시스템 | |
AU2004210406B2 (en) | Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof | |
WO1997045121A1 (fr) | Preparation destinee a une administration percutanee | |
ZA200505629B (en) | Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances and the use thereof | |
EP1196151B1 (en) | Transdermal therapeutic system for administering a calcium antagonist | |
CN101262858A (zh) | 含有比索洛尔的胶粘药物制剂 | |
CN118103036A (zh) | 用于透皮施用替扎尼定的透皮治疗系统 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130201 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140207 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150206 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160211 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170203 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180202 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190201 Year of fee payment: 13 |